Truist Financial
ENTA icon

Truist Financial’s Enanta Pharmaceuticals ENTA Stock Holding History

Truist Financial’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,159
Closed -$211K – 800
2014
Q4 		$211K Sell
4,159
-1,661
-29% -$74.4K 0.01% 744
2014
Q3 		$230K Buy
5,820
+690
+13% +$27.5K 0.01% 695
2014
Q2 		$221K Buy
5,130
+50
+1% +$1.91K 0.01% 728
2014
Q1 		$203K Buy
+5,080
New +$185K 0.01% 749

Other funds holding ENTA

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MVM
McClain Value Management New Canaan, Connecticut $50.9M AUM 16.06% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Truist Financial's ENTA Position: Q1 2015 in Review

Truist Financial sold out of Enanta Pharmaceuticals (ENTA) in Q1 2015, closing a stake of 4,159 shares — an estimated $211K sold.

Truist Financial first reported a position in ENTA in Q1 2014 and held it in 4 quarters. The position peaked at $230K in Q3 2014. 117 funds tracked by Wall St. Rank hold ENTA as of Q1 2015.

  • Truist Financial reported no remaining Enanta Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Truist Financial sold 4,159 Enanta Pharmaceuticals shares in Q1 2015, an estimated $211K.
  • Truist Financial first reported a position in Enanta Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Truist Financial's Enanta Pharmaceuticals position peaked at $230K in Q3 2014.
  • 117 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2015.

Based on Truist Financial's 13F filing for Q1 2015, filed 23 Apr 2015.